Results 131 to 140 of about 5,389 (188)

Fontan circulation versus cirrhotic cardiomyopathy: A comparative overview. [PDF]

Ann Pediatr Cardiol
Shah AH.
europepmc   +1 more source

Prevalence of cirrhotic cardiomyopathy according to different diagnostic criteria: alterations in ultrasonographic parameters of both left and right ventricles before and after stress. [PDF]

Ann Gastroenterol, 2023
Karagiannakis DS, Stefanaki K, Anastasiadis G, Voulgaris T, Vlachogiannakos J.   +4 more
europepmc   +1 more source

Role of Sigma-1 Receptors in the Paraventricular Nucleus and Myocardium during Cirrhotic Cardiomyopathy in Rats. [PDF]

Mol Neurobiol
Yu A, Li Y, Li J, Deng S.
europepmc   +1 more source

Evidence of Ventricular Arrhythmogenicity and Cardiac Sympathetic Hyperinnervation in Early Cirrhotic Cardiomyopathy. [PDF]

Front Physiol, 2021
Liu SH, Lo LW, Chou YH, Lin WL, Tsai TY, Cheng WH, Lin YJ, Chang SL, Hu YF, Chung FP, Huang HC, Chen SA.   +11 more
europepmc   +1 more source

Alcoholic cardiomyopathy [PDF]

, 2016
B. Maisch
core   +1 more source

Fontan-Associated Diastolic Dysfunction and Bile Acids: Mechanistic Parallels With Cirrhotic Cardiomyopathy. [PDF]

JACC Adv
Shah AH.
europepmc   +1 more source

Prevalence and prognostic value of cirrhotic cardiomyopathy as defined according to the proposed new classification. [PDF]

Clin Exp Hepatol, 2021
Cesari M, Frigo AC, Piano S, Angeli P.
europepmc   +1 more source

Apoptosis in Cardiac Conditions Including Cirrhotic Cardiomyopathy. [PDF]

Int J Mol Sci
Yu F, Ryu DG, Yoon KT, Liu H, Lee SS.
europepmc   +1 more source

A Prospective Study of Prevalence and Predictors of Cirrhotic Cardiomyopathy and Its Role in Development of Hepatorenal Syndrome. [PDF]

J Clin Exp Hepatol, 2022
Anikhindi SA, Ranjan P, Kumar M, Mohan R.   +3 more
europepmc   +1 more source

Cirrhotic Cardiomyopathy: Bridging Hepatic and Cardiac Pathophysiology in the Modern Era. [PDF]

J Clin Med
Lupu D, Scârneciu CC, Țînț D, Tudoran C.   +3 more
europepmc   +1 more source